Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/31/13 → 10/30/14 |
Funding
- ICON Clinical Research: $309.52
Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of PF-04950615, in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
- Izzo, Joseph (PI)
Project: Research